Almirall
Marco Stringhini is a highly skilled researcher with extensive experience in the field of pharmaceutical sciences and immunology. Currently serving as a Principal Investigator and Project Leader at Almirall since April 2023, Marco has advanced through various roles including Senior Investigator and Senior Scientist. Prior experience includes a postdoctoral researcher position at the Department of Biomedicine from December 2020 to April 2023, and a doctoral student role at Eidgenössische Technische Hochschule Zürich from January 2017 to November 2020. Early career experiences include a pharmacy apprenticeship at Amavita and internships at the University of Zurich and Scripps Research. Marco holds a Master of Science and a Bachelor degree in Pharmaceutical Sciences from ETH Zürich, completed in 2016 and 2014, respectively.
This person is not in any teams
This person is not in any offices
Almirall
12 followers
Almirall SA is a Spain-based company principally engaged in the pharmaceuticals manufacture. The Company focuses on development and marketing of drugs applied in various therapeutic areas, such as nervous system, gastrointestinal, dermatological, respiratory system, antiinfectives, as well as antineoplastic and immunomodulating agents.